Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Inhibitors targeting the hepatitis C virus (HCV) encoded viroporin, p7 prevent virus release in vitro. HCV can transmit by cell-free particle infection of new target cells and via cell-to-cell dependent contact with limited exposure to the extracellular environment. The role of assembly inhibitors in preventing HCV transmission via these pathways has not been studied. We compared the efficacy of three published p7 inhibitors to inhibit cell-free and cell-to-cell transmission of two chimeric HCV strains encoding genotype 2 (GT2) or 5 (GT5) p7 using a recently developed single cycle co-culture assay. The inhibitors reduced the infectivity of extracellular GT2 and GT5 virus by 80-90% and GT2 virus cell-to-cell transmission by 50%. However, all of the p7 inhibitors had minimal effect on GT5 cell contact dependent transmission. Screening a wider panel of diverse viral genotypes demonstrated that p7 viroporin inhibitors were significantly more effective at blocking cell-free virus than cell-to-cell transmission. These results suggest an altered assembly or trafficking of cell-to-cell transmitted compared to secreted virus. These observations have important implications for the validation, therapeutic design and testing of HCV assembly inhibitors.

Original publication

DOI

10.1016/j.antiviral.2013.10.006

Type

Journal article

Journal

Antiviral Res

Publication Date

12/2013

Volume

100

Pages

636 - 639

Keywords

Assembly, Cell-to-cell, Hepatitis C, Inhibitors, p7, 1-Deoxynojirimycin, Antiviral Agents, Cell Communication, Cell Line, Coculture Techniques, Genotype, Guanidines, Hepacivirus, Humans, Pyrazoles, Reassortant Viruses, Rimantadine, Viral Proteins, Virus Assembly, Virus Attachment, Virus Cultivation